Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 275

Posts Tagged ‘healthcare’

17th Annual Global Healthcare Conference

Posted by fidest press agency su domenica, 18 agosto 2019

Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, Sept. 10, 2019, in New York, N.Y. Glenn David, Executive Vice President and Chief Financial Officer, and Kristin Peck, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, will represent the company and respond to questions from analysts. They are scheduled to present at 12:20 p.m. ET.
Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines, medicines and diagnostics, which are complemented by genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2018, the company generated annual revenue of $5.8 billion with approximately 10,000 employees. For more information, visit http://www.zoetis.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

17th Annual Global Healthcare Conference

Posted by fidest press agency su domenica, 18 agosto 2019

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York on September 9, 2019. José (Joe) Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 1:05 p.m. Eastern Time.The live webcast of Baxter’s presentation can be accessed at http://www.baxter.com and will be available for replay through March 6, 2020.
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Baxter to Present at the 2019 Wells Fargo Healthcare Conference

Posted by fidest press agency su venerdì, 16 agosto 2019

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2019 Wells Fargo Healthcare Conference in Boston on September 5, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:20 p.m. Eastern Time.The live webcast of Baxter’s presentation can be accessed at http://www.baxter.com and will be available for replay through March 3, 2020.
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Healthcare Conference

Posted by fidest press agency su giovedì, 20 giugno 2019

ArQule, Inc. (Nasdaq: ARQL) today announced that Marc Schegerin, Chief Financial Officer and Head of Strategy, will present at the BMO Prescriptions for Success Healthcare Conference on June 25, 2019 at 8:00 a.m. ET at the The Mandarin Oriental New York, New York.The live webcast of the presentation will be available via the “Investors & Media” section of ArQule’s website, http://www.arqule.com, under “Events & Presentations.” A replay of the webcast will be available shortly after the conclusion of the presentation.
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases. ArQule’s mission is to discover, develop and commercialize novel small molecule drugs in areas of high unmet need that will dramatically extend and improve the lives of our patients. Our clinical-stage pipeline consists of four drug candidates, all of which are in targeted, biomarker-defined patient populations, making ArQule a leader among companies our size in precision medicine. ArQule’s pipeline includes: ARQ 531, an orally bioavailable, potent and reversible dual inhibitor of both wild type and C481S-mutant BTK, in phase 1 for patients with B-cell malignancies refractory to other therapeutic options; miransertib (ARQ 092), a potent and selective inhibitor of the AKT serine/threonine kinase, in a planned registrational trial with cohorts in Proteus syndrome and PROS to initiate in 2019, and in phase 1b in combination with the hormonal therapy, anastrozole, in patients with advanced endometrial cancer; ARQ 751, a next generation highly potent and selective AKT inhibitor, in phase 1 for patients with AKT1 and PI3K mutations; and derazantinib, a multi-kinase inhibitor designed to preferentially inhibit the fibroblast growth factor receptor (FGFR) family, in a registrational trial for iCCA in collaboration with Basilea and Sinovant. ArQule’s current discovery efforts are focused on the identification and development of novel kinase inhibitors, leveraging the Company’s proprietary library of compounds.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Healthcare Robotics Engineering Forum

Posted by fidest press agency su giovedì, 20 giugno 2019

Business-to-Business publisher WTWH Media today announced the launch of the Healthcare Robotics Engineering Forum, an international conference and expo focused on easing, speeding and improving the design, development and manufacture of the next generation of commercial class healthcare robotics solutions. The Healthcare Robotics Engineering Forum takes place December 9-10, 2019 at the Santa Clara Convention Center. See http://www.healthcareroboticsforum.com for more details.Dan Kara, VP of Robotics at WTWH Media notes, “Robotics technology is viewed by healthcare professionals, business leaders and government officials as playing a major role in addressing a wide range of pressing healthcare issues, and as a key means of providing better healthcare services while controlling costs. Yet even with considerable amounts of robotics research, investment funding, and available enabling technologies, commercial healthcare robotics output lags. This is largely due to the difficulty of designing and developing robust, functional healthcare robotics systems. The Healthcare Robotic Engineering Forum was specifically developed to address healthcare robotics engineering challenges, so that new systems and solutions can be brought to market faster and more easily.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Goldman Sachs Annual Global Healthcare Conference

Posted by fidest press agency su mercoledì, 5 giugno 2019

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Ilan Daskal, Executive Vice President and CFO, will participate in the Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11, at 10:40 AM (Pacific Time), at the Terranea Resort, Rancho Palos Verdes, California.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018. For more information, please visit http://www.bio-rad.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Jefferies Global Healthcare Conference

Posted by fidest press agency su venerdì, 31 maggio 2019

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced that Steve Hoerter, President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Thursday, June 6 at 1:30 PM ET in New York City.
A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/news-events/events-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a “switched off” or inactivated conformation. These investigational therapies comprise tumor-targeted agents designed to address therapeutic resistance causing mutations and immuno-targeted agents designed to control the activation of immunokinases that suppress critical immune system regulators, such as macrophages. We have used our platform to develop a diverse pipeline of tumor-targeted and immuno-targeted drug candidates designed to improve outcomes for patients with cancer by improving the quality, rate and/or durability of their responses to treatment.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Dicerna™ to Present at the Jefferies 2019 Healthcare Conference

Posted by fidest press agency su giovedì, 30 maggio 2019

Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present a corporate update at the Jefferies 2019 Healthcare Conference on Tuesday, June 4, 2019 at 4:00 pm EST. The conference will be held June 4-7, 2019 in New York.A live audio webcast of the presentation will be accessible within the Investors & Media section on the Dicerna website at http://www.dicerna.com. An archived replay of the webcast will be available on the Company’s website after the conference.
Dicerna™ Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of innovative, subcutaneously delivered RNAi-based therapeutics for the treatment of diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases and viral infectious diseases. Dicerna is leveraging its proprietary GalXC™ RNAi technology platform to build a broad pipeline in these core therapeutic areas, focusing on target genes where connections between these genes and diseases are well understood and documented. Dicerna intends to discover, develop and commercialize novel therapeutics either on its own or in collaboration with pharmaceutical partners. Dicerna has strategic collaborations with Eli Lilly and Company, Alexion Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH. For more information, please visit http://www.dicerna.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Kimberly Hartz Named New CEO of Washington Hospital Healthcare System

Posted by fidest press agency su mercoledì, 15 maggio 2019

The Washington Township Health Care District board has announced that Kimberly Hartz has been named Washington Hospital Healthcare System’s new Chief Executive Officer. Kimberly was selected following Nancy Farber announcing her plans to retire later this year.
Ms. Hartz has been with the Washington Hospital Healthcare System since 1994 and has served in numerous leadership roles, which includes her most recent position as Senior Associate Administrator for Ambulatory Care Services. In this capacity, she has had financial and operational oversight of strategic management, contracting, the neurosciences program, community relations, government relations, human resources, and various inpatient/outpatient ancillary services. Additionally, Ms. Hartz has had responsibility of the Washington Township Medical Foundation and the Development Corporation which includes the Washington Outpatient Surgery Center, Washington Outpatient Rehabilitation Center, Washington Medical Billing, Washington on Wheels, Washington Urgent Care, and Washington Sports Medicine. She was also instrumental in establishing and growing Washington Hospital’s affiliation with UCSF Health, which has brought academic-level care to the local community in the areas of the special care nursery, cancer care, inpatient pediatrics, genetic counseling, prenatal diagnostics, and cardiothoracic surgery. Ms. Hartz was also a critical player in two successful bond campaigns for general obligation bonds for Washington Hospital’s facilities master plan, which includes the recently opened Morris Hyman Critical Care Pavilion.“It has been a privilege to be a part of this amazing organization,” Hartz said. “Under Nancy’s remarkable leadership, we have become one of the nation’s best health care systems, and I am deeply honored to follow in her footsteps.” In addition to Ms. Hartz’ responsibilities with the Washington Hospital Healthcare System, she has been an active member of community nonprofit organizations. She is a member of the Niles Fremont Rotary Club (president 2011-12).Ms. Hartz’ education includes a Master of Science in management and industrial relations from Oxford University in England and a Bachelor of Arts in psychology from Stanford University.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Healthcare Services: Global Market Opportunities & Strategies to 2022

Posted by fidest press agency su giovedì, 9 maggio 2019

The “Healthcare Services Global Market Opportunities And Strategies To 2022” report has been added to ResearchAndMarkets.com’s offering.This report describes and evaluates the market for healthcare services globally. It covers two five-year periods, 2014 to 2018, termed the historic period, and 2018 through 2022, the forecast period.The global market for healthcare services reached a value of nearly $6,707.3 billion in 2018, having grown at a compound annual growth rate (CAGR) of 7.6% since 2014, and is expected to grow at a CAGR of 9.3% to nearly $9,581 billion by 2022.Growth in the historic period resulted from rapid growth in the size of elderly populations, strong economic growth in emerging markets, health insurance reforms and home care/monitoring. Going forward, faster economic growth, technological developments, changes in lifestyles and improved survival and quality of life will drive the growth.Factors that negatively affected growth in the historic period were low healthcare access, and shortages of skilled human resources. Factors that could hinder the growth of this market in the future are government regulations, interest rate increases and government provisions in healthcare services.The healthcare services market is segmented by type of service into hospitals and clinics, physicians and other health practitioners, dental services, residential substance abuse and mental health facilities and all other ambulatory health care services and ambulance services. The hospitals and clinics segment accounted for the largest share of the healthcare services market in 2018 at 55.1%. The hospitals and clinics segment is expected to be the fastest-growing segment going forward at a CAGR of 9.9%.The healthcare services market is segmented by type of end-user gender into female end-users and male end-users. The female end-users segment accounted for the largest share of the healthcare services market in 2018 at 55.3%. The male end-users segment is expected to be the fastest growing segment going forward at CAGR of 9.4%.North America was the largest market for healthcare services, accounting for 41.1% of the global market in 2018. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the Middle East and Asia Pacific will be the fastest growing regions in this market, where growth will be at CAGRs of 14.30% and 14.29% respectively. These will be followed by Africa and Eastern Europe where the market is expected to grow at CAGRs of 13.7% and 11.8% respectively.The global market for healthcare services is highly fragmented. The top ten competitors in the healthcare services market made up 4.9% of the total market in 2018. Major players in the market include the UK National Health Service, Kaiser Permanente, Fresenius Medical Care AG & Co. KGaA, Community Health Systems, Inc., DaVita Inc., and Universal Health Services.Healthcare services is the largest segment of the global healthcare market, accounting for 79.4% of the total. It was followed by pharmaceutical drugs, medical equipment and then the other segments. Biologics is expected to be the fastest-growing segment in the healthcare market going forward at a CAGR of 13.6% during the forecast period.. This will be followed by veterinary healthcare, healthcare services, and pharmaceutical drugs, where the markets are expected to grow at CAGRs of 10.9%, 9.3% and 6.0% respectively.
The top opportunities in the global healthcare services market will arise in hospitals and clinics segment which will gain $1,688.3 billion of global annual sales by 2022. The healthcare services market size will gain the most in China at $657.3 billion. Healthcare services trend-based strategies include increasing the adoption of bundled payments, using digital tools and adopting shared medical appointments by companies. Players adopted strategies in the healthcare services industry include acquiring companies in similar industries to expand their presence and focusing on offering quality services to their patients.To take advantage of these opportunities, the author among a number of other strategies recommends the healthcare services companies to collaborate across verticals and industries to provide value-based healthcare, adopting cloud-based electronic health records, and expanding in emerging markets, among other strategies.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Aurinia Pharmaceuticals to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

Posted by fidest press agency su venerdì, 26 aprile 2019

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the “Company”) today announced that members of the management team will present a corporate overview at the 2019 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 30, 2019 at 8:30am PT (11:30am ET) in Toronto, Ontario.The presentation will be webcast live and can be accessed via the investor section of the Aurinia website, http://www.auriniapharma.com. A replay of the presentation will also be archived on the Company website following the event.
Aurinia Pharmaceuticals Inc. is a late clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations impacted by serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and dry eye syndrome (DES). The company is headquartered in Victoria, British Columbia and focuses its development efforts globally. For further information, see our website at http://www.auriniapharma.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

29th Annual Healthcare Conference

Posted by fidest press agency su domenica, 17 marzo 2019

Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, announced today that Tim Moran, Chief Executive Officer, will present a company overview and update at Oppenheimer’s 29th Annual Healthcare Conference on Wednesday, March 20, 2019 at 2:45 PM ET in New York, NY.
A live audio webcast of the presentation will be accessible on the Events page of the Investors section on the Company’s website at http://www.motusgi.com. The webcast replay will be available approximately two hours after the presentation ends and will be accessible for 90 days.Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy. The Company’s flagship product is the Pure-Vu® System, a U.S. FDA cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard and slim colonoscopes to enable safe and rapid cleansing during the procedure while preserving established procedural workflow and techniques. The Pure-Vu® System has received CE mark approval in Europe. The Pure-Vu® System is currently being introduced on a pilot basis in the U.S. market, and the Company is planning to initiate a full commercial launch focused on the inpatient colonoscopy market in the U.S. and select international markets in 2019. Challenges with bowel preparation for inpatient colonoscopy represent a significant area of unmet need that directly affects clinical outcomes and increases the cost of care in a market segment that comprises approximately 1.5 million annual procedures in the U.S. and approximately 4 million annual procedures worldwide. Motus GI believes the Pure-Vu® System may improve outcomes and lower costs for hospitals by reducing the time to successful colonoscopy, minimizing delayed and incomplete procedures, and improving the quality of an exam. In clinical studies to date, the Pure-Vu® System significantly increased the number of patients with an adequate cleansing level, according to the Boston Bowel Preparation Scale Score, a validated assessment instrument.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Carestream Health to Sell Its Healthcare IT Business to Philips

Posted by fidest press agency su domenica, 10 marzo 2019

Carestream Health has signed an agreement with Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, to sell its healthcare information systems (HCIS) business to Philips.Carestream’s healthcare information systems business unit provides imaging IT solutions to multi-site hospitals, radiology services providers, imaging centers and specialty medical clinics around the world.Carestream’s HCIS business unit provides imaging IT solutions to multi-site hospitals, radiology services providers, imaging centers and specialty medical clinics around the world. The business has developed strong customer relationships in attractive, high-growth healthcare segments and is positioned for continued growth and success.As a result of this acquisition, Philips’ expanded healthcare IT business will feature Carestream’s enterprise imaging platform—including best in class VNA, diagnostic and enterprise viewers, multimedia reporting, workflow orchestrator and clinical, operational and business analytics tools—as part of its broad portfolio.“We have had global success in providing radiology and enterprise imaging IT systems to help medical professionals provide quality care and enhance their operations,” said Ludovic d’Aprea, Carestream’s General Manager for Healthcare Information Solutions. “By becoming part of Philips, the HCIS business will have a greater opportunity to thrive and grow. Both organizations share a commitment to meaningful innovation which is deeply embedded in each company’s culture. Customers will have access to a broader portfolio of healthcare IT solutions to simplify medical image management, enable effective collaboration and enhance patient care.”Like Carestream, Philips has built a strong, global business based on customer focus, world-class technical excellence and continuous innovation.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

29th Annual Healthcare Conference

Posted by fidest press agency su martedì, 19 febbraio 2019

The Barclays Global Healthcare Conference on Wednesday, March 13, 2019 at 3:50 p.m. Eastern Time, at the Loews Miami Beach Hotel in Miami Beach, Florida.
The Oppenheimer 29th Annual Healthcare Conference on Tuesday, March 19, 2019 at 9:10 a.m. Eastern Time, at The Westin New York Grand Central in New York City.
Kevin C. Clark, President and Chief Executive Officer, and William J. Burns, Executive Vice President and Chief Financial Officer will be attending both conferences. An audio webcast and presentation for these conferences will be available on the Company’s website at http://www.crosscountryhealthcare.com in the Investor Relations section under ‘Events and Presentations’.
Cross Country Healthcare is a national leader in providing innovative healthcare workforce solutions and staffing services. Our solutions leverage our nearly 40 years of expertise and insight to assist clients in solving complex labor-related challenges while maintaining high quality outcomes. We are dedicated to recruiting and placing highly qualified healthcare professionals in virtually every specialty and area of expertise. Our diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. Through our national staffing teams and network of 73 office locations, we are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. We are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services. In addition, we provide both retained and contingent placement services for healthcare executives, physicians, and other healthcare professionals.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

37th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su giovedì, 3 gennaio 2019

San Francisco on Wednesday, January 9, 2019 Time: 11:00 a.m. PT Westin St. Francis, Elizabethan D. Merck (NYSE:MRK), Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies, announced today that the company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco Praveen Tipirneni, M.D., president and CEO of Morphic, will provide an overview of the company, its innovative platform for designing integrin oral inhibitors, and anticipated milestones in 2019.Morphic is developing highly differentiated molecules for the treatment of autoimmune diseases, fibrotic diseases, and cancer. In 2018, Morphic announced the completion of a $80 million Series B financing and entered into a research and development collaboration with AbbVie designed to advance a number of Morphic’s oral integrin therapeutics for fibrosis-related indications.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

The Future of AI-Powered Healthcare session and reception

Posted by fidest press agency su giovedì, 3 gennaio 2019

Parc 55 San Francisco, Monday, January 7, 4 pm 55 Cyril Magnin Street; 4th Floor, Cyril Magnin Ballroom. The newly formed Alliance for Artificial Intelligence in Healthcare (AAIH) is sponsoring a panel discussion open to the public, titled “The Future of AI-Powered Healthcare,” on Monday, January 7, in association with the Digital and Medtech Medicine Showcase at the Biotech Showcase in San Francisco. Experts will explore not only the potential impact of machine learning on healthcare systems and drug development, but also provide insights on what investors and partners should consider before engaging in financing or co-development with AI healthcare companies.Preceding the panel, Alex Zhavoronkov, CEO of Insilico Medicine, will provide an introduction, announcing the official launch of AAIH, which will include the organization’s inaugural board meeting on Wednesday, January 9, in San Francisco.
Panelists are Alex Lash, National Biotech Editor, Xconomy; Brandon Allgood, CTO and Co-founder of Numerate; John Baldoni, Senior VP of In-Silico Drug Discovery, GSK; Maria Luisa Pineda, CEO and Co-Founder, Envisagenics; Bill Martin, President and COO, BlackThorn Therapeutics; Angeli Moeller, Co-Lead of AI, Head of Research IT Business Partnering, Bayer; and Ben Newton, CDO, GE Healthcare Life Sciences.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

37th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su domenica, 23 dicembre 2018

Novocure (NASDAQ: NVCR) will participate in the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 9, 2019, in San Francisco. William Doyle, Novocure’s Executive Chairman, will speak on behalf of the company and address questions from analysts. He is scheduled to present at 2:30 p.m. PST.A live audio webcast of the presentation and all presentation materials can be access from the Investor Relations page of Novocure’s website, http://www.novocure.com/investor-relations/, and will be available for replay for at least 14 days following the event.Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called Tumor Treating Fields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and mesothelioma.Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York City. Additionally, the company has offices in Germany, Switzerland, Japan and Israel. For additional information about the company, please visit http://www.novocure.com or follow us at http://www.twitter.com/novocure.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

37th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su venerdì, 21 dicembre 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 8, 2019 at 11:30 a.m. Pacific Time (PT). The presentation will be followed by a Q&A session at noon PT.
The presentation and Q&A session will be webcast live and may be accessed through the investors section of Hologic’s website at http://investors.hologic.com. The webcasts will be available for 30 days.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit http://www.hologic.com

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Cross Country Healthcare to Attend J.P. Morgan’s 37th Annual Healthcare Conference

Posted by fidest press agency su sabato, 15 dicembre 2018

Cross Country Healthcare, Inc. (Nasdaq:CCRN) announced today that Christopher R. Pizzi, Senior Vice President and Chief Financial Officer, will be attending J.P. Morgan’s 37th Annual Healthcare Conference on January 7-10, 2019 at The Westin St. Francis Hotel in San Francisco, California. No formal presentation will be made by Cross Country Healthcare, Inc. at this conference.
Cross Country Healthcare is a national leader in providing innovative healthcare workforce solutions and staffing services. Our solutions leverage our nearly 40 years of expertise and insight to assist clients in solving complex labor-related challenges while maintaining high quality outcomes. We are dedicated to recruiting and placing highly qualified healthcare professionals in virtually every specialty and area of expertise. Our diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. Through our national staffing teams and network of 70 office locations, we are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. We are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services. In addition, we provide both retained and contingent placement services for healthcare executives, physicians, and other healthcare professionals.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Healthcare in Time of a Disaster

Posted by fidest press agency su mercoledì, 28 novembre 2018

While no two disasters are alike, preparation and response for disasters have many similarities and are key to delivering everything from healthcare services to vital resources. These issues will take center stage at the International Conference on Disaster Medicine and Hurricane Resiliency. Healthcare professionals and educators, and persons focused on emergency response and training will converge on Sint Maarten in March for the conference being hosted by American University of the Caribbean School of Medicine (AUC).
The conference, taking place March 8 – 11, 2019, is being organized by AUC in cooperation with Harvard Medical Faculty Physicians of Beth Israel Deaconess Medical Center (HMFP), a physician group that includes emergency medicine experts with global disaster medicine experience. For full conference details and online registration visit: https://ccdm.aucmed.edu.AUC and HMFP are currently working together to develop the Caribbean Center for Disaster Medicine (CCDM), which will be based in Sint Maarten. The CCDM will be center of excellence designed to foster collaboration among professionals responsible for healthcare delivery, disaster preparedness, emergency response and medical education in the region.
AUC is part of an alliance of medical and healthcare educational institutions operated by Adtalem Global Education, which educate doctors, nurses, veterinarians and other health care professionals. With a presence in North America, the Caribbean, the United Kingdom and Brazil, Adtalem institutions provide global resources, clinical partners and leadership in an array of healthcare disciplines to support the Caribbean Center for Disaster Medicine, including One Health Foundation and research facilities that address the intersection of animal, human and environmental health.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »